Zhonghong Pulin Medical Products Co. Ltd. (300981) - Net Assets
Based on the latest financial reports, Zhonghong Pulin Medical Products Co. Ltd. (300981) has net assets worth CN¥5.51 Billion CNY (≈ $806.04 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥7.65 Billion ≈ $1.12 Billion USD) and total liabilities (CN¥2.14 Billion ≈ $313.70 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Zhonghong Pulin Medical Products Co. Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥5.51 Billion |
| % of Total Assets | 71.98% |
| Annual Growth Rate | 41.28% |
| 5-Year Change | 119.92% |
| 10-Year Change | 2835.25% |
| Growth Volatility | 127.38 |
Zhonghong Pulin Medical Products Co. Ltd. - Net Assets Trend (2013–2024)
This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore 300981 asset base for the complete picture of this company's asset base.
Annual Net Assets for Zhonghong Pulin Medical Products Co. Ltd. (2013–2024)
The table below shows the annual net assets of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2024. For live valuation and market cap data, see Zhonghong Pulin Medical Products Co. Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥5.62 Billion ≈ $822.48 Million |
-4.98% |
| 2023-12-31 | CN¥5.92 Billion ≈ $865.55 Million |
-3.55% |
| 2022-12-31 | CN¥6.13 Billion ≈ $897.39 Million |
-6.43% |
| 2021-12-31 | CN¥6.55 Billion ≈ $959.08 Million |
+156.45% |
| 2020-12-31 | CN¥2.56 Billion ≈ $373.98 Million |
+446.49% |
| 2019-12-31 | CN¥467.67 Million ≈ $68.43 Million |
+24.35% |
| 2018-12-31 | CN¥376.10 Million ≈ $55.03 Million |
+17.57% |
| 2017-12-31 | CN¥319.89 Million ≈ $46.81 Million |
+25.32% |
| 2016-12-31 | CN¥255.25 Million ≈ $37.35 Million |
+33.30% |
| 2015-12-31 | CN¥191.49 Million ≈ $28.02 Million |
+26.54% |
| 2014-12-31 | CN¥151.32 Million ≈ $22.14 Million |
+20.55% |
| 2013-12-31 | CN¥125.53 Million ≈ $18.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Zhonghong Pulin Medical Products Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 14620.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥3.29 Billion | 60.04% |
| Common Stock | CN¥390.01 Million | 7.12% |
| Other Comprehensive Income | CN¥100.55 Million | 1.84% |
| Other Components | CN¥1.70 Billion | 31.00% |
| Total Equity | CN¥5.47 Billion | 100.00% |
Zhonghong Pulin Medical Products Co. Ltd. Competitors by Market Cap
The table below lists competitors of Zhonghong Pulin Medical Products Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Whwh
SHG:600576
|
$919.71 Million |
|
Allis Electric Co Ltd
TW:1514
|
$920.17 Million |
|
Der International Home Furnishing Co Ltd
SHE:002631
|
$920.51 Million |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
$920.55 Million |
|
Virtus Investment Partners, Inc.
NYSE:VRTS
|
$918.60 Million |
|
Zhengping Road&Bridge Constr
SHG:603843
|
$918.32 Million |
|
Rayhoo Motor Dies Co Ltd
SHE:002997
|
$918.30 Million |
|
Jiangsu SINOJIT Wind Energy Technology Co Ltd
SHG:601218
|
$917.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Zhonghong Pulin Medical Products Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,768,086,190 to 5,474,102,359, a change of -293,983,831 (-5.1%).
- Net loss of 87,128,895 reduced equity.
- Dividend payments of 215,942,598 reduced retained earnings.
- Share repurchases of 10,025,867 reduced equity.
- Other comprehensive income increased equity by 100,552,861.
- Other factors decreased equity by 81,439,332.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-87.13 Million | -1.59% |
| Dividends Paid | CN¥215.94 Million | -3.94% |
| Share Repurchases | CN¥10.03 Million | -0.18% |
| Other Comprehensive Income | CN¥100.55 Million | +1.84% |
| Other Changes | CN¥-81.44 Million | -1.49% |
| Total Change | CN¥- | -5.10% |
Book Value vs Market Value Analysis
This analysis compares Zhonghong Pulin Medical Products Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.94x to 1.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥1.05 | CN¥14.64 | x |
| 2014-12-31 | CN¥1.67 | CN¥14.64 | x |
| 2015-12-31 | CN¥1.66 | CN¥14.64 | x |
| 2016-12-31 | CN¥1.09 | CN¥14.64 | x |
| 2017-12-31 | CN¥0.94 | CN¥14.64 | x |
| 2018-12-31 | CN¥1.10 | CN¥14.64 | x |
| 2019-12-31 | CN¥1.20 | CN¥14.64 | x |
| 2020-12-31 | CN¥8.74 | CN¥14.64 | x |
| 2021-12-31 | CN¥16.81 | CN¥14.64 | x |
| 2022-12-31 | CN¥15.69 | CN¥14.64 | x |
| 2023-12-31 | CN¥14.99 | CN¥14.64 | x |
| 2024-12-31 | CN¥13.82 | CN¥14.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Zhonghong Pulin Medical Products Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.55%
- • Asset Turnover: 0.34x
- • Equity Multiplier: 1.32x
- Recent ROE (-1.59%) is below the historical average (20.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 2.44% | 0.55% | 1.11x | 3.97x | CN¥-9.42 Million |
| 2014 | 16.59% | 4.26% | 1.20x | 3.26x | CN¥9.90 Million |
| 2015 | 21.93% | 7.00% | 1.05x | 2.98x | CN¥23.02 Million |
| 2016 | 14.89% | 5.38% | 1.13x | 2.45x | CN¥12.54 Million |
| 2017 | 20.24% | 6.83% | 1.36x | 2.17x | CN¥32.89 Million |
| 2018 | 14.98% | 5.86% | 0.99x | 2.58x | CN¥18.85 Million |
| 2019 | 19.09% | 7.62% | 1.09x | 2.30x | CN¥42.50 Million |
| 2020 | 104.22% | 55.74% | 1.30x | 1.44x | CN¥2.41 Billion |
| 2021 | 35.73% | 47.70% | 0.69x | 1.09x | CN¥1.69 Billion |
| 2022 | 1.09% | 4.26% | 0.23x | 1.11x | CN¥-545.02 Million |
| 2023 | -2.27% | -6.22% | 0.30x | 1.22x | CN¥-707.68 Million |
| 2024 | -1.59% | -3.55% | 0.34x | 1.32x | CN¥-634.54 Million |
Industry Comparison
This section compares Zhonghong Pulin Medical Products Co. Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,882,684,540
- Average return on equity (ROE) among peers: 11.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Zhonghong Pulin Medical Products Co. Ltd. (300981) | CN¥5.51 Billion | 2.44% | 0.39x | $918.75 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $858.96 Million | 5.81% | 3.43x | $523.48 Million |
| Blue Sail Medical Co Ltd (002382) | $9.55 Billion | -5.95% | 0.64x | $1.10 Billion |
| Andon Health Co Ltd (002432) | $21.49 Billion | 7.76% | 0.23x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.21 Billion | 3.44% | 0.58x | $1.28 Billion |
| Guangzhou Improve Med Instrument (300030) | $838.26 Million | 3.10% | 0.80x | $376.43 Million |
| QITIAN Technology Group Co Ltd (300061) | $451.92 Million | 8.13% | 0.70x | $924.78 Million |
| Shanghai Tofflon Science Tech (300171) | $113.69 Million | 40.44% | 1.35x | $1.47 Billion |
| Truking Technology Ltd (300358) | $1.67 Billion | 8.57% | 0.72x | $1.02 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $122.42 Million | 28.61% | 0.63x | $770.09 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $520.95 Million | 10.42% | 0.38x | $2.50 Billion |
About Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health products for medical and industrial use in China and internationally. It operates in three segments: Health Protection Division; Safety Infusion Division; and Innovation Incubation Division. The Health Protection Division offers nitrile gloves… Read more